skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Mutation remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
Material Type:
Artigo 		Adicionar ao Meu Espaço

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

Koschmieder, S ; Mughal, T I ; Hasselbalch, H C ; Barosi, G ; Valent, P ; Kiladjian, J-J ; Jeryczynski, G ; Gisslinger, H ; Jutzi, J S ; Pahl, H L ; Hehlmann, R ; Maria Vannucchi, A ; Cervantes, F ; Silver, R T ; Barbui, T

Leukemia, 2016-05, Vol.30 (5), p.1018-1024 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
Material Type:
Artigo 		Adicionar ao Meu Espaço

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

Tefferi, A ; Thiele, J ; Vannucchi, A M ; Barbui, T

Leukemia, 2014-07, Vol.28 (7), p.1407-1413 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Tefferi, A ; Guglielmelli, P ; Lasho, T L ; Rotunno, G ; Finke, C ; Mannarelli, C ; Belachew, A A ; Pancrazzi, A ; Wassie, E A ; Ketterling, R P ; Hanson, C A ; Pardanani, A ; Vannucchi, A M

Leukemia, 2014-07, Vol.28 (7), p.1494-1500 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Material Type:
Artigo 		Adicionar ao Meu Espaço

Classification and Personalized Prognosis in Myeloproliferative Neoplasms

Grinfeld, Jacob ; Nangalia, Jyoti ; Baxter, E. Joanna ; Wedge, David C ; Angelopoulos, Nicos ; Cantrill, Robert ; Godfrey, Anna L ; Papaemmanuil, Elli ; Gundem, Gunes ; MacLean, Cathy ; Cook, Julia ; O’Neil, Laura ; O’Meara, Sarah ; Teague, Jon W ; Butler, Adam P ; Massie, Charlie E ; Williams, Nicholas ; Nice, Francesca L ; Andersen, Christen L ; Hasselbalch, Hans C ; Guglielmelli, Paola ; McMullin, Mary F ; Vannucchi, Alessandro M ; Harrison, Claire N ; Gerstung, Moritz ; Green, Anthony R ; Campbell, Peter J

The New England journal of medicine, 2018-10, Vol.379 (15), p.1416-1430 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Guglielmelli, P ; Lasho, T L ; Rotunno, G ; Score, J ; Mannarelli, C ; Pancrazzi, A ; Biamonte, F ; Pardanani, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Fanelli, T ; Pietra, D ; Rumi, E ; Finke, C ; Gangat, N ; Ketterling, R P ; Knudson, R A ; Hanson, C A ; Bosi, A ; Pereira, A ; Manfredini, R ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Vannucchi, A M ; Tefferi, A

Leukemia, 2014-09, Vol.28 (9), p.1804-1810 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

Vannucchi, A M ; Antonioli, E ; Guglielmelli, P ; Pardanani, A ; Tefferi, A

Leukemia, 2008-07, Vol.22 (7), p.1299-1307 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
Material Type:
Artigo 		Adicionar ao Meu Espaço

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations

PARDANANI, A ; VANNUCCHI, A. M ; PASSAMONTI, F ; CERVANTES, F ; BARBUI, T ; TEFFERI, A

Leukemia, 2011-02, Vol.25 (2), p.218-225 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Mutations and prognosis in primary myelofibrosis
Mutations and prognosis in primary myelofibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mutations and prognosis in primary myelofibrosis

Vannucchi, A M ; Lasho, T L ; Guglielmelli, P ; Biamonte, F ; Pardanani, A ; Pereira, A ; Finke, C ; Score, J ; Gangat, N ; Mannarelli, C ; Ketterling, R P ; Rotunno, G ; Knudson, R A ; Susini, M C ; Laborde, R R ; Spolverini, A ; Pancrazzi, A ; Pieri, L ; Manfredini, R ; Tagliafico, E ; Zini, R ; Jones, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Pietra, D ; Rumi, E ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Tefferi, A

Leukemia, 2013-09, Vol.27 (9), p.1861-1869 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis

Barbui, T ; Thiele, J ; Vannucchi, A M ; Tefferi, A

Blood cancer journal (New York), 2015-08, Vol.5 (8), p.e337-e337 [Periódico revisado por pares]

United States: Springer Nature B.V

Texto completo disponível

Citações Citado por
10
Rethinking the diagnostic criteria of polycythemia vera
Rethinking the diagnostic criteria of polycythemia vera
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rethinking the diagnostic criteria of polycythemia vera

Barbui, T ; Thiele, J ; Vannucchi, A M ; Tefferi, A

Leukemia, 2014-06, Vol.28 (6), p.1191-1195 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2006  (3)
  2. 2006Até2008  (5)
  3. 2009Até2012  (11)
  4. 2013Até2016  (19)
  5. Após 2016  (5)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.